# Adherence Study in COPD Patients

> **NCT02864342** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 138 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD

## Interventions

- **DEVICE:** Arm 1: BreatheMate device with application
- **DEVICE:** Arm 2: BreatheMate device without application

## Key facts

- **NCT ID:** NCT02864342
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-12
- **Primary completion:** 2017-10-31
- **Final completion:** 2017-10-31
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2018-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864342, "Adherence Study in COPD Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02864342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*